Discontinued — last reported Q2 '23
ResMed Total Sleep and Respiratory Care — Net revenue remained flat by 0.0% to $931.25M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 17.2%, from $794.32M to $931.25M. Over 2 years (FY 2021 to FY 2023), Total Sleep and Respiratory Care — Net revenue shows an upward trend with a 14.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Rising revenue suggests strong demand for both new patient setups and ongoing replacement cycles for masks, which are critical for long-term recurring revenue.
This metric measures the aggregate net revenue derived from the sale of devices and masks within the sleep and respirato...
Similar to 'Product Revenue' or 'Device and Consumable Revenue' reported by other respiratory and sleep therapy device manufacturers.
rmd_segment_total_sleep_and_respiratory_care_net_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $780.33M | $794.32M | $794.32M | $794.32M | $794.32M | $931.25M | $931.25M | $931.25M | $931.25M |
| QoQ Change | — | +1.8% | +0.0% | +0.0% | +0.0% | +17.2% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +1.8% | +17.2% | +17.2% | +17.2% | +17.2% |